Reduced frequency of circulating CD4+CD25brightCD127lowFOXP3+ regulatory T cells in primary myelofibrosis-Reference-Cited by-同舟云学术

Reduced frequency of circulating CD4+CD25brightCD127lowFOXP3+ regulatory T cells in primary myelofibrosis

Published:2016-09-22 Issue:12 Volume:128 Page:1660-1662
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Massa Margherita¹,Campanelli Rita²,Fois Gabriela²,Villani Laura²,Bonetti Elisa²,Catarsi Paolo²,Poletto Valentina²,Viarengo Gianluca³,De Amici Mara⁴,Rosti Vittorio²,Gale Robert Peter⁵,Barosi Giovanni²

Affiliation:

1. Biotechnology Research Area,

2. Center for the Study of Myelofibrosis, Biotechnology Research Area,

3. Immunohematology and Transfusion Service, and

4. Division of Pediatrics, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo Foundation, Pavia, Italy; and

5. Haematology Research Centre, Division of Haematology, Department of Medicine, Imperial College London, London, United Kingdom

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/128/12/1660/1396349/1660.pdf

Reference26 articles.

1. An immune dysregulation in MPN.;Barosi;Curr Hematol Malig Rep,2014

2. Development and function of CD25+CD4+ regulatory T cells.;Fehérvari;Curr Opin Immunol,2004

3. Human CD4+ CD25+ regulatory T cells suppress NKT cell functions.;Azuma;Cancer Res,2003

4. CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells.;Cederbom;Eur J Immunol,2000

5. CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms.;Maloy;J Exp Med,2003

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PD-1/PD-L1, MDSC Pathways, and Checkpoint Inhibitor Therapy in Ph(-) Myeloproliferative Neoplasm: A Review;International Journal of Molecular Sciences;2022-05-23

2. The Power of Extracellular Vesicles in Myeloproliferative Neoplasms: “Crafting” a Microenvironment That Matters;Cells;2021-09-04

3. Expression profile analysis reveals hub genes that are associated with immune system dysregulation in primary myelofibrosis;Hematology;2021-01-01

4. Plasma sIL-2Rα levels are associated with disease progression in myelofibrosis with JAK2V617F but not CALR mutation;Leukemia Research;2020-03

5. The role of circulating monocytes and JAK inhibition in the infectious-driven inflammatory response of myelofibrosis;OncoImmunology;2020-01-01